- alias::
  ICD-11_Code::
- ## Etiology
  background-color:: blue
	- ### Causative Agents
	- ### Risk Factors
- ## Epidemiology
  background-color:: blue
	- ### Incidence
	- ### Prevalence
		- ### Demographics
	- ### Geographic Distribution
- ## Pathophysiology
  background-color:: blue
	- ### Mechanism of Disease
	- ### Affected Systems/Organs
- ## Clinical Features #ent-prof-card #card
  background-color:: blue
  deck:: #ENT
  id:: 49ee1cd7-ce1f-4c21-a273-6e222282ac02
	- ### Signs and Symptoms
		- #### Symptoms
		- #### Signs
	- ### Stages or Classification
	- ### Diagnostic Criteria
- ## Diagnosis
  background-color:: blue
	- ### Clinical Diagnosis
		- #### Classical Presentation
		- #### Probable Diagnosis
	- ### Investigatiosn #ent-prof-card #card
	  deck:: #ENT
	  id:: 6756b6b8-254c-446c-b927-42fa2a1c0e7d
	- ### Laboratory Tests
	- ### Imaging Studies
	- ### Differential Diagnosis
	- ### Confirmation of Diagnosis
- ## Management and Treatment #ent-prof-card #card
  background-color:: blue
  deck:: #ENT
  id:: 90c38ac3-b1b0-4c9d-b6f0-463912e4337a
	- ### Medical Treatment
	- ### Surgical Options
	- ### Lifestyle and Dietary Recommendations
	- ### Follow-up
- ## Prognosis
  background-color:: blue
	- ### Expected Course
		- #### With Treatment
		- #### Without Treatment
			- ##### Possible Complications
			- ##### Long-Term Effects
	- ### Survival Rates
		- #### With Treatment
		- #### Without Treatment
	- ### Quality of Life Considerations
- ## Prevention
  background-color:: blue
	- ### Health Education
	- ### Community Approach
	- ### Screening Programs
	- ### Lifestyle Modifications
- ## Patient Education and Support
  background-color:: blue
	- ### Educational Resources
	- ### Support Groups
	- ### Counseling Options
- ## Recent Research and Developments
  background-color:: blue
	- ### Ongoing Clinical Trials
	- ### Recent Advances
- ## Key Literature
  background-color:: blue
- ## Guidelines and Protocols
  background-color:: blue